Tirzepatide Dosage Guide: Escalation Schedule, Reconstitution & Unit Chart
Tirzepatide (GLP-2) 2.5–15 mg escalation as reported in published trials, reconstitution ratios, and mg-to-unit conversion tables.
By PX1 Research Team · August 4, 2026
Tirzepatide (GLP-2) escalation in the literature
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Published trial protocols are notable for how conservative the escalation is: a long initiation period followed by 2.5 mg steps at four-week intervals.
| Study phase | Reported weekly amount | Typical duration |
|---|---|---|
| Initiation | 2.5 mg | 4 weeks |
| Step 1 | 5 mg | 4 weeks |
| Step 2 | 7.5 mg | 4 weeks |
| Step 3 | 10 mg | 4 weeks |
| Step 4 | 12.5 mg | 4 weeks |
| Maximal | 15 mg | remainder |
Reported discontinuations in trials clustered in the first two steps and were predominantly gastrointestinal, which is why compressed escalation is not represented in the published data.
Reconstitution reference
A 30 mg vial with 3 mL bacteriostatic water gives 10 mg/mL:
| Target | Volume | Insulin units (U-100) |
|---|---|---|
| 2.5 mg | 0.25 mL | 25 |
| 5 mg | 0.50 mL | 50 |
| 7.5 mg | 0.75 mL | 75 |
| 10 mg | 1.00 mL | 100 |
Tirzepatide vs retatrutide in study data
Retatrutide adds glucagon-receptor agonism to the GIP/GLP-1 mechanism, and Phase 2 data reported larger weight-change effect sizes at the top arms — with a correspondingly higher adverse-event rate. Tirzepatide has the deeper published safety dataset. Full breakdown: Retatrutide vs Tirzepatide vs Semaglutide.
Product page: GLP-2 (Tirzepatide).
All figures below are reported from published laboratory literature and are provided for informational and laboratory-research context only. PX1 Research supplies compounds for laboratory and research use only — not for human or veterinary use.
Most-researched PX1 compounds
- Buy retatrutide online99%+ HPLC retatrutide, lot-matched COA, 10mg / 20mg / 30mg / 40mg vials.View page
- GHK-Cu copper peptide for saleCopper tripeptide-1, 50mg and 100mg research vials, US cGMP synthesised.View page
- Research tesamorelin peptideTesamorelin 10mg and 20mg, growth-hormone-releasing factor analogue.View page
- CJC-1295 no DAC + ipamorelin blendPre-blended secretagogue research pairing, 10mg and 20mg presentations.View page
- Buy AOD-9604 peptideModified hGH fragment 176-191, lyophilised research vials with public COA.View page
- KLOW blend peptide for saleKPV, LL-37, GHK-Cu and BPC-157 five-peptide research blend, 80mg total.View page
PX1 Research Team
PX1 Research is a primary US cGMP-compliant peptide manufacturer. Our team handles solid-phase synthesis, HPLC purification, lyophilization and in-house analytical testing — every batch ships with a lot-specific Certificate of Analysis.
See how we manufacture